US9814255B2 - Method for producing purple sweet potato juice and dried powder - Google Patents
Method for producing purple sweet potato juice and dried powder Download PDFInfo
- Publication number
- US9814255B2 US9814255B2 US13/475,984 US201213475984A US9814255B2 US 9814255 B2 US9814255 B2 US 9814255B2 US 201213475984 A US201213475984 A US 201213475984A US 9814255 B2 US9814255 B2 US 9814255B2
- Authority
- US
- United States
- Prior art keywords
- psp
- purple sweet
- sweet potato
- juice
- slurry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 244000017020 Ipomoea batatas Species 0.000 title claims abstract description 88
- 235000002678 Ipomoea batatas Nutrition 0.000 title claims abstract description 87
- 235000011389 fruit/vegetable juice Nutrition 0.000 title claims abstract description 34
- 239000000843 powder Substances 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 102000004190 Enzymes Human genes 0.000 claims abstract description 34
- 229940088598 enzyme Drugs 0.000 claims abstract description 34
- 108090000790 Enzymes Proteins 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 33
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 32
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 32
- 239000004410 anthocyanin Substances 0.000 claims abstract description 32
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 32
- 239000004382 Amylase Substances 0.000 claims abstract description 13
- 108010065511 Amylases Proteins 0.000 claims abstract description 13
- 102000013142 Amylases Human genes 0.000 claims abstract description 13
- 108010059820 Polygalacturonase Proteins 0.000 claims abstract description 13
- 235000019418 amylase Nutrition 0.000 claims abstract description 13
- 108010093305 exopolygalacturonase Proteins 0.000 claims abstract description 13
- 108091005804 Peptidases Proteins 0.000 claims abstract description 12
- 239000004365 Protease Substances 0.000 claims abstract description 12
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 12
- 229940059442 hemicellulase Drugs 0.000 claims abstract description 12
- 108010002430 hemicellulase Proteins 0.000 claims abstract description 12
- 239000013049 sediment Substances 0.000 claims abstract description 12
- 108010059892 Cellulase Proteins 0.000 claims abstract description 11
- 229940106157 cellulase Drugs 0.000 claims abstract description 11
- 239000012141 concentrate Substances 0.000 claims abstract description 11
- 150000002989 phenols Chemical class 0.000 claims abstract description 11
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims abstract description 10
- 102100022624 Glucoamylase Human genes 0.000 claims abstract description 10
- 229920002472 Starch Polymers 0.000 claims abstract description 8
- 235000019698 starch Nutrition 0.000 claims abstract description 8
- 239000008107 starch Substances 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- 230000008569 process Effects 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000002002 slurry Substances 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 238000003306 harvesting Methods 0.000 claims description 8
- 238000007781 pre-processing Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 6
- 238000010025 steaming Methods 0.000 claims description 4
- 230000009849 deactivation Effects 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 230000009268 pathologic speech processing Effects 0.000 claims 8
- 208000032207 progressive 1 supranuclear palsy Diseases 0.000 claims 8
- 238000010438 heat treatment Methods 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- 238000002156 mixing Methods 0.000 claims 2
- 239000010414 supernatant solution Substances 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 235000013325 dietary fiber Nutrition 0.000 abstract description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 238000001291 vacuum drying Methods 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 5
- 244000078534 Vaccinium myrtillus Species 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 4
- -1 flavonoid compounds Chemical class 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000001728 nano-filtration Methods 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- 229920001277 pectin Polymers 0.000 description 4
- 239000001814 pectin Substances 0.000 description 4
- 235000010987 pectin Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 238000001223 reverse osmosis Methods 0.000 description 4
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 3
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 230000003143 atherosclerotic effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007407 health benefit Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 230000004297 night vision Effects 0.000 description 3
- 235000012015 potatoes Nutrition 0.000 description 3
- 238000011085 pressure filtration Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000031836 visual learning Effects 0.000 description 3
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000010907 Cyclooxygenase 2 Human genes 0.000 description 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000003777 Interleukin-1 beta Human genes 0.000 description 2
- 108090000193 Interleukin-1 beta Proteins 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 2
- 230000010398 acute inflammatory response Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000007278 cognition impairment Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036252 glycation Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 230000000946 synaptic effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 101710095339 Apolipoprotein E Proteins 0.000 description 1
- 102100029470 Apolipoprotein E Human genes 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- 206010058842 Cerebrovascular insufficiency Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000177965 Vaccinium lamarckii Species 0.000 description 1
- 235000013473 Vaccinium lamarckii Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940070404 citrus bioflavonoids Drugs 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000003931 cognitive performance Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000004300 dark adaptation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229910001448 ferrous ion Inorganic materials 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical group OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000006883 memory enhancing effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004065 mitochondrial dysfunction Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 238000011302 passive avoidance test Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000001242 postsynaptic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003518 presynaptic effect Effects 0.000 description 1
- 230000004647 pro-inflammatory pathway Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006886 spatial memory Effects 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 230000003966 vascular damage Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/105—Sweet potatoes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/12—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops of potatoes
- A23L19/15—Unshaped dry products, e.g. powders, flakes, granules or agglomerates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
- A23L2/08—Concentrating or drying of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
Definitions
- the present invention relates generally to food processing technology, more particularly, to method and process of producing purple sweet potato juice and dried powder using an enzyme complex of amylase, hemicellulase, pectinase, cellulase, glucoamylase, and protease.
- Purple sweet potato has recently received attention as a healthful food.
- Purple sweet potato is rich in anthocyanins and phenolic compounds.
- Anthocyanins are the deeply pigmented red, purple and blue flavonoid compounds that have significant physiological effects and bioactivity in humans.
- Anthocyanins are well known from medical research for their capillary health stabilizing effects, increasing the strength of the capillary wall to help reduce bleeding. They are part of the vitamin P complex of bioflavonoids which is related to rutin and citrus bioflavonoids.
- anthocyanins One of the earliest studied sources of anthocyanins has been from Bilberry ( Vaccinium myrtillus ) or European Blueberry which is a smaller, wild type of low bush blueberry that has a long history of use in European countries for improving eye health and night vision. Some earlier studies using much higher dosages of anthocyanins showed promising effects for myopia and night vision. More recent studies with anthocyanins in the oligomeric form derived from grapes have shown a beneficial effect for myopia and night vision at lower to moderate dosages (Lee J, 2005), and for video terminal eye fatigue (Nakaishi H, 2000).
- Purple sweet potato and its anthocyanins have shown similar brain and cognitive effects as blueberries in both in vitro and in vivo studies (Wu D M, 2008; Ye J, 2009; Shan Q, 2009; Wang Y J 2009; Park 2010).
- the extract inhibited lipid peroxidation from ferrous ion and ascorbic acid in rat brain homogenates (Cho, 2003) and strongly improved cognitive performance, assessed by passive avoidance test in ethanol treated mice.
- Purple sweet potato has been shown to repair d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins.
- the effect of purple sweet potato on the spatial learning and memory has been demonstrated by studies in vivo in a water maze with mice treated with d-galactose. Memory formation depends on pre- and post-synaptic proteins, but low levels can be improved by treatment with purple sweet potato extract (Wu D M, 2008).
- Anthocyanins from purple sweet potato suppress the development of atherosclerotic lesions. Vascular damage and insufficiency is also implicated in cerebrovascular insufficiency, stroke and aging brain pathologies. Studies have shown there are protective effects of anthocyanins from purple sweet potato against low-density lipoprotein (LDL) oxidation and atherosclerotic lesion development in mice (Kano M, 2005; Miyazaki K, 2008). It protected LDL against oxidation more effectively than other anthocyanins and 1-ascorbic acid in vitro. Atherosclerotic plaque area was reduced to about half of controls, oxidative stress markers, and soluble vascular cell adhesion molecule-1 were also reduced (Miyazaki K, 2008).
- LDL low-density lipoprotein
- Amyloid-beta peptide is implicated in Alzheimer's disease pathology and is known to induce redox imbalance, mitochondrial dysfunction and caspase activation, resulting in neuronal cell death.
- An in vitro study of purple sweet potato anthocyanins decreased the toxicity of amyloid peptide free radicals, lipid peroxidation, and cell death which may help prevent loss of cognitive function, help sustain energy production in mitochondria, and reduce risk of dementia (Ye, 2010).
- Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging and the anthocyanins improved learning and memory ability, suppressed cyclooxygenase-2 (COX-2) and inducible nitric oxide synthases (iNOS) expression in mouse brain, decreased excess overproduction of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) in the mouse brain.
- TNF-alpha tumor necrosis factor-alpha
- IL-1beta interleukin-1beta
- IL-6 interleukin-6
- purple sweet potato Another area of health benefits of purple sweet potato is its ability to reduce damage to blood vessels by excess sugar in the blood which causes protein glycation, also a known factor in beta amyloid synthesis (Park, 2010). Blood pressure reducing effects can also decrease damage to the brain. It has been shown that purple sweet potato has anti-hypertensive effects (Shindo, 2007).
- Purple sweet potato has long been staple food in China, Japan, and Korea because of its taste and its health benefits. Purple sweet potato can be prepared in many creative ways for both sweet and savory taste. For example, purple sweet potato can be steamed, boiled, baked, stewed, and made into dumplings. In the West, purple sweet potato finds its niche. Many lifestyle and health care experts such as livestrong.com and Dr. Oz, highly recommend consuming purple sweet potato. Markets for purple sweet potato chips and purple sweet potato pies are emerging.
- purple sweet potato In order to reap its maximum health benefit, one has to consume a large quantity of purple sweet potato on a regular base.
- purple sweet potato is still considered to be a novelty item. It is not always available in the general markets. Very often one has to search for them in Asian groceries.
- purple sweet potato is a flatulence-producing food because it is high in certain polysaccharides, especially oligosaccharides such as inulin. For people who are prone to bloating and suffer from flatulence, purple sweet potato may make the problem worse.
- the purple sweet potato liquid extract produced with this invention contains as much as 500 mg of anthocyanins and as much as 6,155 mg total phenolic compounds per 100 gm of the liquid, which is equivalent to consuming a 100 gm of baked purple sweet potato 1 without the starch.
- Purple sweet potato is heavily used in the industry to provide natural pigments alternative to synthetic colorants.
- the process to extract PSP powders is designed primarily to obtain high purity and high color anthocyanin pigments.
- the process is complex and costly. A large amount of anthocyanins, phenolic compounds and other active ingredients are also lost in the process.
- the process also creates environmental pollution because it uses citric acid or hydrochloric acid solution and acidified ethanol solution as the extraction solvent to extract the anthocyanin pigments.
- existing process suffers from the low extraction rate of anthocyanins, high production cost, loss of nutritional content and creating waste and pollutant.
- the purpose of the present invention is to overcome the deficiencies of the existing manufacturing process and to produce a natural purple sweet potato juice that is free from starch, rich in anthocyanins, phenolic compounds, and soluble dietary fiber with low viscosity, attractive color, and with natural sweetness.
- the present invention comprises in a process for producing purple sweet potato juice and dried powder rich in content of anthocyanins, active phenolic compounds, soluble dietary fiber, and other nutrients, with natural flavors, natural sweetener, active low viscosity without pollutants to the environment and suitable for human consumption.
- FIG. 1 is the high level flow chart for illustrating the process of this invention. It is comprised of 5 stages, namely, preprocessing, liquefying, enzyme treatment, filtration and harvesting. Then the products are packaged for shipping.
- FIG. 2 depicts the details of the pre-processing process to soak, wash and sterilize fresh or dried purple sweet potatoes so that they are ready for liquefaction.
- FIG. 3 illustrates the liquefying process, in which, color fixation is completed before liquefaction.
- FIG. 4 shows a three-step enzyme treatment process. After preparation, the liquefied PSP is treated with amylase, followed by an enzyme complex of hemicellulase, pectinase, cellulase, glucoamylase, and protease.
- FIG. 5 shows the process of centrifuge separation and filtration of the PSP supernatant with membrane and nano filters or through reverse osmosis to obtain the purified PSP juice.
- FIG. 6 depicts the steps to harvest PSP concentrate and PSP Dried Powder.
- FIG. 1 is a detailed description of a manufacturing process of purple sweet potato juice and dried powder by using an enzyme complex of amylase, hemicellulase, pectinase, cellulase, glucoamylase, and protease according to the present invention.
- the process is partitioned into five phases, namely, preprocessing, liquefying, enzyme treatment, filtration and harvesting as depicted in FIG. 1 .
- preprocessing phase at block 101 raw fresh potatoes or dried purple sweet potatoes are sterilized.
- the sterilized purple sweet potatoes then are liquefied at liquefying phases at block 102 .
- enzyme treatment on liquefied PSP produces PSP suspension which goes through the separation and filtration phase at block 104 to produce purified PSP juice.
- purified PSP juice is concentrated to produce PSP concentrates for packaging, and at block 106 , PSP dried powder is collected and packaged. The details of each phase are illustrated in the following figures.
- FIG. 2 shows the details of the preprocessing phase.
- Fresh purple sweet potato is soaked and washed with water at step 201 .
- the process can also accommodate dried purple sweet potatoes.
- the dried purple sweet potatoes will be soaked, washed and macerated with filtered water at step 202 .
- the cleaned and macerated purple sweet potatoes will be sterilized by steaming at 80° C. to 125° C. for 20 to 80 minutes at step 203 .
- the steaming also serves as a process to de-activate the enzymes in the potatoes.
- a batch of sterilized purple sweet potatoes is obtained and is ready to be liquefied in liquefying treatment phase at step 204 which is described in FIG. 3 .
- FIG. 3 illustrates the liquefying process.
- the batch of sterilized purple sweet potatoes is then ground and blended to obtain a consistent puree at step 301 .
- Step 302 involves color fixation by adjusting the pH to 2.5-5.5 by using citric acid.
- Color fixed PSP puree is then liquefied at step 303 by adding treated water. For fresh raw purple sweet potato, treated water of 0.5 to 3 times its weight is added. For dried purple sweet potatoes, it is necessary to add 2 to 8 times its weight of treated water.
- the liquefied purple sweet potatoes are ready for the enzyme treatment phase at step 304 which is described in FIG. 4 .
- FIG. 4 depicts the Enzyme Treatment process.
- the liquefied purple sweet potato is warmed up to 90° C. to 110° C. for 1 to 6 minutes at step 401 .
- the temperature is maintained at 40° C. to 65° C. for 1 to 3 hours.
- Amylase is an enzyme that catalyzes the breakdown of starch into maltodextrins and glucoamylase converts maltodextrins to maltose and glucose.
- pH value of cooled down liquefied PSP is adjusted between 3.0 to 5.0, and then 5 to 36 U/g of an enzyme complex (hemicellulase 0 to 15%, pectinase 0 to 20%, cellulase 0 to 15%, glucoamylase 35% to 95%, and protease 0 to 15%) is added to the liquefied PSP while maintaining the temperature between 40.degree. C. to 70.degree. C. for 1 to 5 hours.
- Hemicellulase breaks cross-linking polymeric hemicellulose so the cell wall becomes more susceptible to other enzymatic defragmentation.
- Pectinase breaks down pectin, a polysaccharide substrate that is found in the cell walls of the purple sweet potatoes converting it to glucose. Pectinase also attacks dissolved pectin. Consequently, its viscosity is reduced because of the degradation of soluble high molecular weight materials in the juice. Rupture of cell wall membranes is a major key to increase the juice yield. It should be noted that pectin is not the only ingredient of cell wall. Cellulase is used here to attack the cellulose content of the cell wall, which helps improve further the yield of the juice by breaking open the cells to release more active pigments contain in cell vacuoles.
- Glucoamylase breaks the bonds near the ends of large carbohydrates such as the remaining starches, releasing maltose and free glucose.
- protease hydrolyses proteins in the slurry to amino acids that further lowers the viscosity of the juice.
- the combined enzymatic treatment converts the slurry mixture to a lower viscosity purple sweet potato juice by removing the starch and pectins for a better yield of the juice.
- the PSP suspension is then heated to 80.degree. C. to 90.degree. C. for 1 minute to 10 minutes for enzyme deactivation.
- the resulting purple sweet potato suspension is ready to be separated at step 405 which is further described in FIG. 5 .
- FIG. 5 describes the separation and purification processes.
- the PSP cloudy suspension obtained from the enzyme treatment phase is press-filtered or centrifuged to separate the supernatant from the sediment at step 501 .
- the sediment will be harvested to produce tried PSP powder at step 504 .
- the supernatant is further purified by membrane filtration at step 502 .
- the liquid thus obtained has a Brix value of 6° to 12°.
- nano-filtration and/or reverse osmosis at step 503 a purified purple sweet potato juice is obtained, which is now ready for harvesting at step 504 .
- FIG. 6 shows the harvesting process.
- the purified purple sweet potato juice is subject to a controlled temperature vacuum concentration process at 25° C. to 85° C., at step 601 and a final purple sweet potato concentrate with Brix 55° is obtained.
- the purple sweet potato concentrate has more than 0.5% anthocyanins (w/w) and 1 to 2% phenolic compounds (w/w) and ready to be packaged at step 603 .
- the sediment can be combined with concentrated juice to be vacuum concentrated and dried to yield the purple sweet potato powder at step 602 for packaging at step 603 .
- a purified purple sweet potato powder can be obtained from centrifuged sediment and filtered residues and dried in vacuum.
- a purple sweet potato powder can be obtained from centrifuged sediment and filtered residue and dried in vacuum.
- a purified purple sweet potato powder can be obtained from centrifuged sediment and filtered residue and dried in vacuum.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A method for preparing a purple sweet potato concentrate that is free from starch, rich in anthocyanins, phenolic compounds, minerals, and soluble dietary fiber with low viscosity, attractive color, and with natural sweetness is presented. The method first prepares and liquefies the purple sweet potatoes and fixes the colorization by adjusting the pH value. Next, amylase and an enzyme complex of hemicellulase, pectinase, cellulase, glucoamylase and protease are added in sequence under conditions effective to produce the juice with the above mentioned properties. The juice is then centrifuged and membrane-filtered to produce a purified purple sweet potato juice which is vacuum-concentrated to yield a purple sweet potato concentrate. Purple sweet potato powder can be obtained by vacuum drying the sediment and concentrate mixture.
Description
The present invention relates generally to food processing technology, more particularly, to method and process of producing purple sweet potato juice and dried powder using an enzyme complex of amylase, hemicellulase, pectinase, cellulase, glucoamylase, and protease.
Purple sweet potato has recently received attention as a healthful food. Purple sweet potato (PSP) is rich in anthocyanins and phenolic compounds. Anthocyanins are the deeply pigmented red, purple and blue flavonoid compounds that have significant physiological effects and bioactivity in humans. Anthocyanins are well known from medical research for their capillary health stabilizing effects, increasing the strength of the capillary wall to help reduce bleeding. They are part of the vitamin P complex of bioflavonoids which is related to rutin and citrus bioflavonoids.
One of the earliest studied sources of anthocyanins has been from Bilberry (Vaccinium myrtillus) or European Blueberry which is a smaller, wild type of low bush blueberry that has a long history of use in European countries for improving eye health and night vision. Some earlier studies using much higher dosages of anthocyanins showed promising effects for myopia and night vision. More recent studies with anthocyanins in the oligomeric form derived from grapes have shown a beneficial effect for myopia and night vision at lower to moderate dosages (Lee J, 2005), and for video terminal eye fatigue (Nakaishi H, 2000).
Purple sweet potato and its anthocyanins have shown similar brain and cognitive effects as blueberries in both in vitro and in vivo studies (Wu D M, 2008; Ye J, 2009; Shan Q, 2009; Wang Y J 2009; Park 2010). The extract inhibited lipid peroxidation from ferrous ion and ascorbic acid in rat brain homogenates (Cho, 2003) and strongly improved cognitive performance, assessed by passive avoidance test in ethanol treated mice.
Purple sweet potato has been shown to repair d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. The effect of purple sweet potato on the spatial learning and memory has been demonstrated by studies in vivo in a water maze with mice treated with d-galactose. Memory formation depends on pre- and post-synaptic proteins, but low levels can be improved by treatment with purple sweet potato extract (Wu D M, 2008).
Anthocyanins from purple sweet potato suppress the development of atherosclerotic lesions. Vascular damage and insufficiency is also implicated in cerebrovascular insufficiency, stroke and aging brain pathologies. Studies have shown there are protective effects of anthocyanins from purple sweet potato against low-density lipoprotein (LDL) oxidation and atherosclerotic lesion development in mice (Kano M, 2005; Miyazaki K, 2008). It protected LDL against oxidation more effectively than other anthocyanins and 1-ascorbic acid in vitro. Atherosclerotic plaque area was reduced to about half of controls, oxidative stress markers, and soluble vascular cell adhesion molecule-1 were also reduced (Miyazaki K, 2008).
Amyloid-beta peptide is implicated in Alzheimer's disease pathology and is known to induce redox imbalance, mitochondrial dysfunction and caspase activation, resulting in neuronal cell death. An in vitro study of purple sweet potato anthocyanins decreased the toxicity of amyloid peptide free radicals, lipid peroxidation, and cell death which may help prevent loss of cognitive function, help sustain energy production in mitochondria, and reduce risk of dementia (Ye, 2010). Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging and the anthocyanins improved learning and memory ability, suppressed cyclooxygenase-2 (COX-2) and inducible nitric oxide synthases (iNOS) expression in mouse brain, decreased excess overproduction of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) in the mouse brain. By decreasing pro-inflammatory pathways purple sweet potato color suppresses lipopolysaccharide-induced acute inflammatory responses in the brain (Wang Y J, 2009).
Another area of health benefits of purple sweet potato is its ability to reduce damage to blood vessels by excess sugar in the blood which causes protein glycation, also a known factor in beta amyloid synthesis (Park, 2010). Blood pressure reducing effects can also decrease damage to the brain. It has been shown that purple sweet potato has anti-hypertensive effects (Shindo, 2007).
Purple sweet potato has long been staple food in China, Japan, and Korea because of its taste and its health benefits. Purple sweet potato can be prepared in many creative ways for both sweet and savory taste. For example, purple sweet potato can be steamed, boiled, baked, stewed, and made into dumplings. In the West, purple sweet potato finds its niche. Many lifestyle and health care experts such as livestrong.com and Dr. Oz, highly recommend consuming purple sweet potato. Markets for purple sweet potato chips and purple sweet potato pies are emerging.
In order to reap its maximum health benefit, one has to consume a large quantity of purple sweet potato on a regular base. Unfortunately, purple sweet potato is still considered to be a novelty item. It is not always available in the general markets. Very often one has to search for them in Asian groceries. Furthermore, purple sweet potato is a flatulence-producing food because it is high in certain polysaccharides, especially oligosaccharides such as inulin. For people who are prone to bloating and suffer from flatulence, purple sweet potato may make the problem worse. The purple sweet potato liquid extract produced with this invention contains as much as 500 mg of anthocyanins and as much as 6,155 mg total phenolic compounds per 100 gm of the liquid, which is equivalent to consuming a 100 gm of baked purple sweet potato1 without the starch.
Purple sweet potato is heavily used in the industry to provide natural pigments alternative to synthetic colorants. The process to extract PSP powders is designed primarily to obtain high purity and high color anthocyanin pigments. However, the process is complex and costly. A large amount of anthocyanins, phenolic compounds and other active ingredients are also lost in the process. The process also creates environmental pollution because it uses citric acid or hydrochloric acid solution and acidified ethanol solution as the extraction solvent to extract the anthocyanin pigments. In summary, existing process suffers from the low extraction rate of anthocyanins, high production cost, loss of nutritional content and creating waste and pollutant.
The purpose of the present invention is to overcome the deficiencies of the existing manufacturing process and to produce a natural purple sweet potato juice that is free from starch, rich in anthocyanins, phenolic compounds, and soluble dietary fiber with low viscosity, attractive color, and with natural sweetness.
The present invention comprises in a process for producing purple sweet potato juice and dried powder rich in content of anthocyanins, active phenolic compounds, soluble dietary fiber, and other nutrients, with natural flavors, natural sweetener, active low viscosity without pollutants to the environment and suitable for human consumption. This is accomplished by, (a) soaking, washing, sterilizing fresh or dried purple sweet potatoes at the same time de-activating the enzymes in them, (b) grinding the potatoes and fixing the color desirable for drinks and beverages by adjusting the pH value between 2.5 to 5.5, (c) for fresh raw purple sweet potatoes, liquefying the puree by adding 0.5 to 3 times of treated water to its weight; for dried purple sweet potatoes, liquefying the puree by adding 2 to 8 times of treated water to its weight, (d) warming up the liquid to 90.degree. C. to 110.degree. C. for 1 to 6 minutes, (e) adjusting the pH value to 4.0 to 7.0 before treating the liquid with amylase, maintaining the temperature at 40.degree. C. to 65.degree. C. for 1 to 3 hours, (f) adjusting its pH value between 3.0 to 5.0, then adding the enzyme complex of pectinase, cellulase, hemicellulase, glucoamylase, and protease, maintaining the temperature at 40.degree. C. to 65.degree. C. for 1 to 5 hours, (h) separate the part of the enzyme treated PSP mixture from the solids through a centrifuge, followed by filtering the liquid with a membrane filter and a nano filter or via reverse osmosis membrane to obtain the purified PSP juice, (i) vacuum-concentrating the purified PSP juice to obtain PSP concentrate, (j) vacuum and dry the sediment to obtain PSP dried powder.
The accompanying drawings, where like numerals indicate like components, illustrate embodiments of the invention.
Reference will now be made in detail to some embodiments of the invention, examples of which are illustrated in the accompanying drawings. Although the present invention has been described in connection with certain specific embodiments for instructional purposes, the present invention is not limited thereto. Accordingly, various modifications, adaptations, and combinations of various features of the described embodiments can be practiced without departing from the scope of the invention as set forth in the claims.
At step 403, pH value of cooled down liquefied PSP is adjusted between 3.0 to 5.0, and then 5 to 36 U/g of an enzyme complex (hemicellulase 0 to 15%, pectinase 0 to 20%, cellulase 0 to 15%, glucoamylase 35% to 95%, and protease 0 to 15%) is added to the liquefied PSP while maintaining the temperature between 40.degree. C. to 70.degree. C. for 1 to 5 hours. Hemicellulase breaks cross-linking polymeric hemicellulose so the cell wall becomes more susceptible to other enzymatic defragmentation. Pectinase breaks down pectin, a polysaccharide substrate that is found in the cell walls of the purple sweet potatoes converting it to glucose. Pectinase also attacks dissolved pectin. Consequently, its viscosity is reduced because of the degradation of soluble high molecular weight materials in the juice. Rupture of cell wall membranes is a major key to increase the juice yield. It should be noted that pectin is not the only ingredient of cell wall. Cellulase is used here to attack the cellulose content of the cell wall, which helps improve further the yield of the juice by breaking open the cells to release more active pigments contain in cell vacuoles. Glucoamylase breaks the bonds near the ends of large carbohydrates such as the remaining starches, releasing maltose and free glucose. Finally, protease hydrolyses proteins in the slurry to amino acids that further lowers the viscosity of the juice. The combined enzymatic treatment converts the slurry mixture to a lower viscosity purple sweet potato juice by removing the starch and pectins for a better yield of the juice. At step 404, The PSP suspension is then heated to 80.degree. C. to 90.degree. C. for 1 minute to 10 minutes for enzyme deactivation. The resulting purple sweet potato suspension is ready to be separated at step 405 which is further described in FIG. 5 .
The following examples are provided to illustrate embodiments of the present invention but are by no means intended to limit its scope.
One example of producing PSP juice and powers using the process in the present invention is described. 18 Kg raw fresh purple sweet potatoes are soaked, washed and sterilized and at the same time de-activating the existing enzymes. Then they are ground and blended while its color is fixed by adjusting its pH value to 5.5. Next, 45 Kg water is added and the puree is liquefied. The liquid purple sweet potato juice is then warmed up to 90.degree. C. to 110.degree. C. for 6 minutes. Adjust its pH value to 5.5, add 10 SKBU/g of amylase solution, and maintain the temperature at 50.degree. C. to 55.degree. C. Let the solution rest for 2 hours. Then adjust the pH value to 4.0 to 4.5 and then add 26 U/g the enzyme complex of hemicellulase, pectinase, cellulase, glugoamylase, and protease. Maintain the temperature between 45.degree. C. to 60.degree. C. Let it rest for 3 hours. The solution is then filtered by pressure filtration and centrifugation to remove the residues. The solution is further filtered with a microporous membrane with inlet pressure of 0.15 to 0.25 mpa, resulting a Brix.sup.°10 solution. Then the solution is pushed through a nano filtration system and a vacuum low-temperature scraper film evaporator to obtain a Brix.sup.°60 purple sweet potato extract that contains 0.52% of anthocyanin and 1.2% of phenolic compounds. A purified purple sweet potato powder can be obtained from centrifuged sediment and filtered residues and dried in vacuum.
Another example of producing PSP juice and powers using the process in the present invention is described. 15 Kg raw fresh purple sweet potatoes are soaked, washed and sterilized and at the same time de-activating the existing enzymes. Then they are ground and blended while its color is fixed by adjusting its pH value to 5.0. Next, 40 Kg water is added and the puree is liquefied. The liquid purple sweet potato juice is then warmed up to 90° C. to 110° C. for 5 minutes. Adjust its pH value to 5.0, add 10 SKBU/g of amylase solution, and maintain the temperature at 60° C. to 65° C. Let the solution rest for 2.5 hours. Then adjust the pH value to 4.0 to 4.5 and then add 22 U/g the enzyme complex of hemicellulase, pectinase, cellulose, glugoamylase, and protease. Maintain the temperature between 55° C.-65° C. Let it stand for 2.5 hours. The solution is then filtered by pressure filtration and centrifugation to remove the residues. The solution is further filtered with a microporous membrane with inlet pressure of 0.15 to 0.25 mpa, resulting in a Brix°8 solution. Then the solution is pushed through a nano filtration system and a vacuum low-temperature scraper film evaporator to obtain a Brix°56 purple sweet potato extract that contains 0.5% of anthocyanin and 1% of phenolic compounds. A purple sweet potato powder can be obtained from centrifuged sediment and filtered residue and dried in vacuum.
One more example of producing PSP juice and powers using the process in the present invention is described. 15 Kg dried purple sweet potatoes are soaked, washed and sterilized and at the same time de-activating the existing enzymes. Then they are ground and blended while its color is fixed by adjusting its pH value to 5.0.Next, 65 Kg water is added and the puree is liquefied. The liquid purple sweet potato juice is then warmed up to 90.degree. C. to 110.degree. C. for 5 minutes. Adjust its pH value to 5.0, add 8 SKBU/g of amylase solution, and maintain the temperature at 60.degree. C. to 65.degree. C. Let the solution rest for 3 hours. Then adjust the pH value to 4.0 to 4.5 and then add 33 U/g the enzyme complex of hemicellulase, pectinase, cellulase, glugoamylase, and protease Maintain the temperature between 60.degree. C. to 65.degree. C. Let it rest for 4.5 hours. The solution is then filtered by pressure filtration and centrifugation to remove the residues. The solution is further filtered with a microporous membrane with inlet pressure of 0.15 to 0.25 mpa, resulting a Brix.sup.°8 solution. Then the solution is pushed through a nano filtration system, reverse osmosis system and a vacuum low-temperature scraper film evaporator to obtain a Brix.sup.°55 purple sweet potato extract that contains 0.46% of anthocyanin and 0.8% of phenolic compounds. A purified purple sweet potato powder can be obtained from centrifuged sediment and filtered residue and dried in vacuum.
- [Andres-Lacueva, 2005] Andres-Lacueva C, Shukitt-Hale B, Galli R L, Jauregui O, Lamuela-Raventos R M, Joseph J A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci. 2005 April; 8(2):111-20. PMID: 16053243.
- [Cho, 2003] Cho J, Kang J S, Long P H, Jing J, Back Y, Chung K S. Antioxidant and memory enhancing effects of purple sweet potato anthocyanin and cordyceps mushroom extract. Arch Pharm Res. 2003 October; 26(10):821-5
- [Kano, 2005] Kano M, Takayanagi T, Harada K, Makino K, Ishikawa F. Antioxidative activity of anthocyanins from purple sweet potato, Ipomoera batatas cultivar Ayamurasaki. Biosci Biotechnol Biochem. 2005 May; 69(5):979-88.
- [Lau, 2005] Lau F C, Shukitt-Hale B, Joseph J A. The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging. 2005 December; 26 Suppl 1:128-32. Epub 2005 Sep. 27. Review. PubMed PMID: 16194581.
- [Lee, 2005] Lee J, Lee H K, Kim C Y, Hong Y J, Choe C M, You T W, Seong G J. Purified high-dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects. Br J Nutr. 2005 June; 93(6):895-9.
- [Miyazaki, 2008] Miyazaki K, Makino K, Iwadate E, Deguchi Y, Ishikawa F. Anthocyanins from purple sweet potato Ipomoea batatas cultivar Ayamurasaki suppress the development of atherosclerotic lesions and both enhancements of oxidative stress and soluble vascular cell adhesion molecule-1 in apolipoprotein E-deficient mice. J Agric Food Chem. 2008 Dec. 10; 56(23):11485-92.
- [Nakaishi, 2000] Nakaishi H, Matsumoto H, Tominaga S, Hirayama M. Effects of black current anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans. Altern Med Rev. 2000 December; 5(6):553-62.
- [Park, 2010] Park K H, Kim J R, Lee J S, Lee H, Cho K H. Ethanol and water extract of purple sweet potato exhibits anti-atherosclerotic activity and inhibits protein glycation. J Med Food. 2010 February; 13(1):91-8.
- [Pilaczynska-Szczesniak, 2005] Pilaczynska-Szczesniak L, Skarpanska-Steinborn A, Deskur E, Basta P, Horoszkiewicz-Hassan M. The influence of chokeberry juice supplementation on the reduction of oxidative stress resulting from an incremental rowing ergometer exercise. Int J Sport Nutr Exerc Metab. 2005 February; 15(1):48-58.
- [Ramirea, 2005] Ramirez M R, Izquierdo I, do Carmo Bassols Raseira M, Zuanazzi J A, Barros D, Henriques A T. Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res. 2005 December; 52(6):457-62. Epub 2005 Aug. 10.
- [Shan, 2009] Shan Q, Lu J, Zheng Y, Li J, Zhou Z, Hu B, Zhang Z, Fan S, Mao Z, Wang Y J, Ma D. Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by d-galactose. J Biomed Biotechnol. 2009; 2009:564737. Epub 2009 Oct. 26.
- [Shindo, 2007] Shindo M, Kasai T, Abe A, Kondo Y. Effects of dietary administration of plant-derived anthocyanin-rich colors to spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 2007 February; 53(1):90-3.
- [Wang, 2009] Wang Y J, Zheng Y L, Lu J, Chen G Q, Wang X H, Feng J, Ruan J, Sun X, Li C X, Sun Q J. Purple sweet potato color suppresses lipopolysaccharide-induced acute inflammatory response in mouse brain. Neurochem Int. 2010 February; 56(3):424-30. Epub 2009 Nov. 24.
- [Wang, 2005] Wang Y, Chang C F, Chou J, Chen H L, Deng X, Harvey B K, Cadet J L, Bickford P C. Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage. Exp Neurol. 2005 May; 193(1):75-84.
- [Wu, 2008] Wu D M, Lu J, Zheng Y L, Zhou Z, Shan Q, Ma D F. Purple sweet potato color repairs d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. Neurobiol Learn Mem. 2008 July; 90(1):19-27. Epub 2008 Mar. 7.
- [Ye, 2009] Ye J, Meng X, Yan C, Wang C. Effect of purple sweet potato anthocyanins on beta-amyloid-mediated PC-12 cells death by inhibition of oxidative stress. Neurochem Res. 2010 March; 35(3):357-65. Epub 2009 Sep. 22.
Claims (7)
1. A method for producing a purified purple sweet potato (PSP) concentrate, the method comprising the phases of:
a preprocessing PSPs phase including washing and sterilizing PSPs;
a liquefying PSPs phase including grinding and blending serialized PSPs and adding citric acid to fix the color of a PSP puree;
an enzyme treatment phase including heating the liquefied PSP slurry, adjusting pH value of the PSP slurry using citric acid and amylase solution, after a cool down period again adjusting the pH value of the PSP slurry using citric acid and enzyme complex and heating the PSP slurry for enzyme deactivation, wherein the enzyme complex consists of 0.1% to 15% hemicellulase, 0.1% to 20% pectinase, 0.1% to 15% of cellulase, 35% to 95% of glucoamylase and 0.1% to 15% of protease, wherein the enzyme complex facilitates the extraction and concentration of anthocyanins and phenolics from the PSP;
a filtration phase including press-filtering PSP suspension solution to separate supernatant from PSP sediment, purifying the supernatant solution by membrane filtration and nano-filtering purified supernatant to obtain a purified PSP juice; and
a harvesting phase comprising low temperature vacuum concentrating the purified PSP juice to yield the PSP concentrate that is more than 55° Brix, with low viscosity and that contains more than 0.5% of anthocyanin and more than 1% of phenolic compounds.
2. The method of claim 1 , wherein the preprocessing phase comprising the steps of:
washing and soaking PSPs, including fresh purple sweet potatoes or dried purple sweet potatoes, with purified water; and
sterilizing cleaned PSPs by steaming at 80° C. to 125° C. for 20 to 80 minutes, wherein the steaming also serves as a process to de-activate the enzymes in the PSPs.
3. The method of claim 1 , wherein the liquefying phase comprising the steps of:
grinding and blending sterilized PSPs to obtain a consistent puree;
fixing the color of the PSP puree by adjusting the pH value of the PSP puree to 2.5 to 5.5 using citric acid; and
liquefying the PSP puree by adding treated water.
4. The method of claim 3 , wherein liquefying the purple sweet potato puree involves adding 0.5 to 3 times its weight of treated water for fresh raw purple sweet potato, and involves adding 2 to 8 times its weight of treated water for dried purple sweet potato.
5. The method of claim 1 , wherein the enzyme treatment phase comprising the steps of:
heating up liquefied PSP slurry to 90° C. to 110° C. for 1 to 6 minutes and waiting the slurry to cool down to the room temperature at 10° C. to 35° C.;
adjusting pH value of the PSP slurry to 4.0 to 7.0 by using citric acid and adding 5 to 15 SKBU/g amylase solution to the slurry, wherein amylase is an enzyme that catalyzes the break down and convert the starch of the purple sweet potatoes into sugars;
maintaining the temperature of PSP slurry at 40° C.-65° C. for 1 to 3 hours before cooling down to the room temperature at 10° C. to 35° C.; and
adjusting the pH value of PSP sediment to 3.0 to 5.0 by citric acid and adding 5-36 U/g of an enzyme complex consists of 0.1% to 15% hemicellulase, 0.1% to 20% pectinase, 0.1% to 15% of cellulase, 35% to 95% of glucoamylase and 0.1% to 15% of protease while maintaining the temperature between 40° C. to 70° C. for 1 to 5 hours to produce a lower viscosity PSP juice by removing the starch and with a better yield of the juice; and
heating the PSP slurry to 80° C. to 90° C. for 1 to 10 minutes for the purpose of enzyme deactivation.
6. The method of claim 1 , wherein the filtration phases comprising the steps of:
press-filtering or centrifuging the PSP suspension solution to separate supernatant from the PSP sediment;
purifying the supernatant solution by membrane filtration to obtain the PSP liquid with a Brix value of 6° to 12°; and
nano-filtering purified supernatant to obtain the purified PSP juice.
7. The method of claim 1 , wherein the harvesting phase further comprising:
vacuum concentrating and drying the PSP sediment and the PSP concentrate mixture to produce a PSP dried powder with more than 1% of anthocyanin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/475,984 US9814255B2 (en) | 2012-05-20 | 2012-05-20 | Method for producing purple sweet potato juice and dried powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/475,984 US9814255B2 (en) | 2012-05-20 | 2012-05-20 | Method for producing purple sweet potato juice and dried powder |
Publications (2)
Publication Number | Publication Date |
---|---|
US20130309355A1 US20130309355A1 (en) | 2013-11-21 |
US9814255B2 true US9814255B2 (en) | 2017-11-14 |
Family
ID=49581495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/475,984 Active 2033-12-27 US9814255B2 (en) | 2012-05-20 | 2012-05-20 | Method for producing purple sweet potato juice and dried powder |
Country Status (1)
Country | Link |
---|---|
US (1) | US9814255B2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014321711B2 (en) | 2013-09-19 | 2019-11-14 | The Research Foundation For The State University Of New York | Methods and materials for treating diabetes or liver steatosis |
CN103734820A (en) * | 2013-12-03 | 2014-04-23 | 浙江平湖谷元元营养饮品有限公司 | Purple sweet potato beverage |
CN103829186A (en) * | 2014-03-21 | 2014-06-04 | 南京飞马食品有限公司 | Production method of honey purple potato food |
CN104592406B (en) * | 2014-10-11 | 2017-03-29 | 湖北师范学院 | Extracting method of Rhizoma Dioscoreae esculentae polysaccharide and application thereof |
CN104687067A (en) * | 2015-02-10 | 2015-06-10 | 贵州省紫薏生物科技有限责任公司 | Purple sweet potato dietary fibers and preparation method thereof |
AU2016243516A1 (en) | 2015-03-27 | 2017-11-09 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
CN104738383A (en) * | 2015-04-06 | 2015-07-01 | 朱增伟 | Method for processing starch rich in sweet potato pectin |
CN105265970B (en) * | 2015-09-09 | 2018-05-15 | 江苏省农业科学院 | A kind of raw method squeezed legal system and make purple sweet potato juice |
CN105581203B (en) * | 2016-01-29 | 2018-10-23 | 武汉爱民制药股份有限公司 | A kind of bioanalysis imitates the preparation method of fresh squeezing purple sweet potato primary pulp drink |
EP3592859A1 (en) | 2017-03-07 | 2020-01-15 | Syddansk Universitet | Methods for obtaining natural colourants from plant based materials |
CN107467441B (en) * | 2017-07-28 | 2020-07-31 | 江苏徐淮地区徐州农业科学研究所 | Preparation method of purple sweet potato anthocyanin beverage |
CN107752030A (en) * | 2017-10-17 | 2018-03-06 | 上海天源植物制品有限公司 | A kind of production technology of the purple sweetpotato extract solution rich in anthocyanidin |
CN108719867A (en) * | 2018-04-23 | 2018-11-02 | 西北农林科技大学 | A kind of big jujube products and preparation method thereof rich in oligosaccharide |
US11191289B2 (en) | 2018-04-30 | 2021-12-07 | Kraft Foods Group Brands Llc | Spoonable smoothie and methods of production thereof |
CN109043517A (en) * | 2018-08-06 | 2018-12-21 | 湖南省农产品加工研究所 | A kind of purple composite instant powder and preparation method thereof |
CN109275919A (en) * | 2018-10-23 | 2019-01-29 | 五邑大学 | Method for extracting soluble dietary fiber from potato dregs by microwave-assisted sodium hexametaphosphate |
CN116171112A (en) * | 2020-06-26 | 2023-05-26 | 可口可乐公司 | Whole soybean food and preparation method thereof |
CN111705046B (en) * | 2020-06-28 | 2022-03-22 | 烟台大学 | Technology for extracting anthocyanin and beta-amylase from purple sweet potato starch processing wastewater |
CN113170857B (en) * | 2020-08-04 | 2022-06-03 | 湖北根聚地农业发展股份有限公司 | Purple sweet potato noodles with high anthocyanin preservation rate and making method thereof |
CN113951519A (en) * | 2021-12-03 | 2022-01-21 | 武汉轻工大学 | A kind of purple potato protein polyphenol complex and its preparation method and application |
CN118436059B (en) * | 2024-05-31 | 2025-01-21 | 湖北薯芋农业科技有限公司 | A fresh-eating sweet potato saccharification process |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3385711A (en) | 1964-06-03 | 1968-05-28 | Inst Divi Thomae Foundation | Orange juice process |
US3754932A (en) | 1971-04-16 | 1973-08-28 | Us Agriculture | Proteare and pectmare additive to citrus juices |
US3988204A (en) | 1974-10-31 | 1976-10-26 | Joseph E. Seagram & Sons, Inc. | Production of glucoamylase for conversion of grain mashes in the production of grain spirits |
US4371552A (en) | 1980-02-13 | 1983-02-01 | Novo Industri A/S | Prune juice production using cellulase |
US4569853A (en) | 1981-07-16 | 1986-02-11 | The Procter & Gamble Company | Grapefruit juice concentrate |
US5298275A (en) | 1990-11-06 | 1994-03-29 | Amaranathan Balasingham | Juice processing methods |
US5500241A (en) | 1991-11-06 | 1996-03-19 | Balasingham; Amaranathan | Kiwifruit juice product |
US5525154A (en) * | 1994-11-04 | 1996-06-11 | Universite Laval | Method for the hydrolysis of starchy materials by sweetpotato endogenous amylases |
US5902616A (en) | 1995-08-04 | 1999-05-11 | Van Den Bergh Foods Co., Division Of Conopco, Inc. | Process for preparing a tomato sauce using a pectinase enzyme |
US5935826A (en) | 1997-10-31 | 1999-08-10 | National Starch And Chemical Investment Holding Corporation | Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |
US6410064B1 (en) | 1999-08-06 | 2002-06-25 | Toru Akazawa | Method of processing soybean by use of a pectinase, processed soybean obtained, and food containing the processed soybean |
US6432192B1 (en) * | 2000-02-23 | 2002-08-13 | Flint Ink Corporation | Process for manufacturing pigments |
US20030134006A1 (en) * | 1998-11-20 | 2003-07-17 | Chukwu Uchenna N. | Method of vegetable processing |
CN1460694A (en) * | 2003-05-30 | 2003-12-10 | 江苏省农业科学院 | Process for extracting anthocyanin of purple sweet potato by utilizing citric acid solution |
US6723355B2 (en) | 2000-05-10 | 2004-04-20 | Westfalia Separator Ag | Method for extracting fruit and vegetable juices |
US7056544B2 (en) | 2000-04-14 | 2006-06-06 | Novozymes, Inc. | Methods for producing potato products |
US20090035441A1 (en) | 2004-01-19 | 2009-02-05 | Takayuki Hirashima | Beverage containing fine pulp, process for producing the same and edible material |
US20090246343A1 (en) | 2008-03-28 | 2009-10-01 | Wild Flavors, Inc. | Stable Natural Color Process, Products and Use Thereof |
US7833560B2 (en) | 2005-03-18 | 2010-11-16 | Kraft Foods R & D, Inc. | Beverage derived from the extract of coffee cherry husks and coffee cherry pulp |
US20100291244A1 (en) | 2009-05-14 | 2010-11-18 | Il Hwa Co., Ltd. | Methods for preparing a fermented ginseng concentrate or powder |
-
2012
- 2012-05-20 US US13/475,984 patent/US9814255B2/en active Active
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3385711A (en) | 1964-06-03 | 1968-05-28 | Inst Divi Thomae Foundation | Orange juice process |
US3754932A (en) | 1971-04-16 | 1973-08-28 | Us Agriculture | Proteare and pectmare additive to citrus juices |
US3988204A (en) | 1974-10-31 | 1976-10-26 | Joseph E. Seagram & Sons, Inc. | Production of glucoamylase for conversion of grain mashes in the production of grain spirits |
US4371552A (en) | 1980-02-13 | 1983-02-01 | Novo Industri A/S | Prune juice production using cellulase |
US4569853A (en) | 1981-07-16 | 1986-02-11 | The Procter & Gamble Company | Grapefruit juice concentrate |
US5298275A (en) | 1990-11-06 | 1994-03-29 | Amaranathan Balasingham | Juice processing methods |
US5500241A (en) | 1991-11-06 | 1996-03-19 | Balasingham; Amaranathan | Kiwifruit juice product |
US5525154A (en) * | 1994-11-04 | 1996-06-11 | Universite Laval | Method for the hydrolysis of starchy materials by sweetpotato endogenous amylases |
US5902616A (en) | 1995-08-04 | 1999-05-11 | Van Den Bergh Foods Co., Division Of Conopco, Inc. | Process for preparing a tomato sauce using a pectinase enzyme |
US5935826A (en) | 1997-10-31 | 1999-08-10 | National Starch And Chemical Investment Holding Corporation | Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |
US20030134006A1 (en) * | 1998-11-20 | 2003-07-17 | Chukwu Uchenna N. | Method of vegetable processing |
US6410064B1 (en) | 1999-08-06 | 2002-06-25 | Toru Akazawa | Method of processing soybean by use of a pectinase, processed soybean obtained, and food containing the processed soybean |
US6432192B1 (en) * | 2000-02-23 | 2002-08-13 | Flint Ink Corporation | Process for manufacturing pigments |
US7056544B2 (en) | 2000-04-14 | 2006-06-06 | Novozymes, Inc. | Methods for producing potato products |
US6723355B2 (en) | 2000-05-10 | 2004-04-20 | Westfalia Separator Ag | Method for extracting fruit and vegetable juices |
CN1460694A (en) * | 2003-05-30 | 2003-12-10 | 江苏省农业科学院 | Process for extracting anthocyanin of purple sweet potato by utilizing citric acid solution |
US20090035441A1 (en) | 2004-01-19 | 2009-02-05 | Takayuki Hirashima | Beverage containing fine pulp, process for producing the same and edible material |
US7833560B2 (en) | 2005-03-18 | 2010-11-16 | Kraft Foods R & D, Inc. | Beverage derived from the extract of coffee cherry husks and coffee cherry pulp |
US20090246343A1 (en) | 2008-03-28 | 2009-10-01 | Wild Flavors, Inc. | Stable Natural Color Process, Products and Use Thereof |
US20100291244A1 (en) | 2009-05-14 | 2010-11-18 | Il Hwa Co., Ltd. | Methods for preparing a fermented ginseng concentrate or powder |
Non-Patent Citations (1)
Title |
---|
Steed et al., Anthocyanin Content, Antioxidant Activity, and Selected Physical Properties of Flowable Purple-Fleshed Sweetpotato Purees, Journal of Food Science, vol. 73, No. 5, 2008. * |
Also Published As
Publication number | Publication date |
---|---|
US20130309355A1 (en) | 2013-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9814255B2 (en) | Method for producing purple sweet potato juice and dried powder | |
Dimou et al. | Valorization of fruits by-products to unconventional sources of additives, oil, biomolecules and innovative functional foods | |
CN104000252B (en) | A kind of blueberry waxy corn drink juice and processing method thereof | |
CN104256801B (en) | A kind of blueberry pulp improves the method for crushing juice rate and anthocyanidin content | |
CN104287021B (en) | A kind of preparation method of natural olive original juice | |
US20100015316A1 (en) | Method for producing grape extract with high ORAC value, and grape extract so produced | |
CN101301016A (en) | Camellia functional instant tea powder and preparation method thereof | |
CN104432339A (en) | Method for preparing dragon fruit and lychee drink | |
CN107232461A (en) | A kind of processing method of purple potato blueberry composite beverage | |
CN105876544A (en) | Lycium chinensis fruit and lycium ruthenicum fruit compound drink and manufacture method thereof | |
CN103989220B (en) | Blueberry and lotus root juice and processing method thereof | |
CN104872312B (en) | A kind of processing method of vine tea beverage | |
CN1843138A (en) | Tea drink and its preparation method | |
CN106319013A (en) | Preparation method of antioxidant sea-buckthorn polypeptide | |
CN108530411A (en) | A method of the extraction and purification anthocyanidin from wild cherry certain kind of berries slag | |
CN113768032B (en) | Preparation method and application of glycosylated bamboo shoot protein peptide | |
CN101416763A (en) | Bee pollen beverage and preparation method thereof | |
KR101897591B1 (en) | Anti-oxidative activity berry beverage containing solidity materials and manufacturing method thereby | |
KR101792346B1 (en) | Preparation Method of the Fermentation Vinegar of Chestnut and Ogalpi Fruit | |
CN104171097A (en) | Health care milk tea and preparation process thereof | |
CN102318856A (en) | Edible fungi beverage low in calories and preparation method thereof | |
CN104082410B (en) | A kind of hairy grape collagen polypeptide Ca yogurt | |
CN107279407A (en) | A kind of blueberry leaf red date and ginger juice tea beverage and preparation method thereof | |
CN101991641B (en) | Preparation method of antioxidation nitraria tangutorum bobr extractive | |
CN106071452A (en) | A kind of additive-free Semen Maydis fruit and vegerable health compound beverage and production method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DRACO NATURAL PRODUCTS INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WONG, WANG-CHAN;WU, JERRY;CHEN, JAMES-JIANGUO;AND OTHERS;SIGNING DATES FROM 20131108 TO 20131117;REEL/FRAME:031695/0143 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |